- Home
- / 3sbio
3sbio
Stock Price
$6.8
2023-09-27
Market Capitalization
$16.2 B
2023-09-27
Revenue
¥6.9 B
FY, 2022
3sbio Summary
Company Summary
- Overview
- 3sbio (三生制药集团) is a company that develops biopharmaceuticals. Its product lineup covers several treatment fields including cancer, autoimmune, kidney disease, metabolism, and dermatology.
- Type
- Public
- Status
- Active
- Founded
- 1993
- HQ
- Shenyang, CN | view all locations
- Website
- http://www.3sbio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
3sbio Financials
Summary Financials
- Revenue (FY, 2022)
- ¥6.9B
- Gross profit (FY, 2022)
- ¥6.1B
- Net income (FY, 2022)
- ¥1.9B
- Cash (FY, 2022)
- ¥2.1B
- EBIT (FY, 2022)
- ¥1.8B
- Enterprise value
- $18.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2023